Solutions
Use Cases
Healthcare
Drug and Device Development
Academia/Research
Wellness and Longevity
Therapies
Hypertension
Renal Disease
Heart Failure
Maternal Health
Brain Health
Metabolic Health
COPD
Men’s Health
Sports Medicine
Products
CONNEQT Pulse
SphygmoCor XCEL
Oscar 2
Digital Solutions
SphygmoCor Technology
Company
About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Technology & IP
Investors
Resources
Sample Case Studies
Clinical Research Repository
Customer Support
Solutions
Use Cases
Healthcare
Drug and Device Development
Academia/Research
Wellness and Longevity
Therapies
Hypertension
Renal Disease
Heart Failure
Maternal Health
Brain Health
Metabolic Health
COPD
Men’s Health
Sports Medicine
Products
CONNEQT Pulse
SphygmoCor XCEL
Oscar 2
Digital Solutions
SphygmoCor Technology
Company
About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Technology & IP
Careers
Investors
Resources
Case Studies
Clinical Research Repository
Customer Support
Legal
Privacy Policy
Disclaimer
Acceptable Use Policy
Contact Us
✕
No results
See all results
Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study
Aortic Hemodynamics in Postmenopausal Women Following Cessation of Hormone Therapy
December 6, 2017
Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease
January 22, 2018
Chronic Kidney Disease
Research
Journal of Clinical Hypertension
Anna Oliveras MD, PhD, Pedro Armario MD, PhD, Laia Sans MD, PhD, et. al.
Contact Us
No results
See all results